Association between left ventricular function and paraprotein type in patients with multiple
myeloma
Jeong-Eun Yi, Sung-Eun Lee, Hae-Ok Jung, Chang-Ki Min, Ho-Joong Youn
Korean J Intern Med. 2017;32(3):459-468. Published online 2016 Apr 6 DOI: https://doi.org/10.3904/kjim.2015.339
Citations to this article as recorded by 
Impaired coronary flow reserve by hyperviscosity in a mouse model of non-light chain multiple myeloma: a mechanism of coronary flow impairment at the capillary level
Aleksandra Paterek, Filip Rolski, Mateusz Surzykiewicz, Zofia Pilch, Karol Czubak, Grażyna Hoser, Jakub Gołąb, Dominika Nowis, Tomasz Skirecki, Michał Mączewski
Cardiovascular Research.2025; 121(13): 2070. CrossRef
Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple Myeloma
Aleksandra Paterek, Marta Oknińska, Zofia Pilch, Anna Sosnowska, Kavita Ramji, Urszula Mackiewicz, Jakub Golab, Dominika Nowis, Michał Mączewski
Cancers.2023; 15(7): 2191. CrossRef
Comparing the efficacy of different dexamethasone regimens for maintenance treatment of multiple myeloma in standard-risk patients non-eligible for transplantation
Sai-Ling Hu, Min Liu, Jun-Yu Zhang
World Journal of Clinical Cases.2022; 10(32): 11712. CrossRef
Capillary electrophoresis analysis of N‐glycosylation changes of serum paraproteins in multiple myeloma
Zsuzsanna Kovacs, Adam Simon, Zoltan Szabo, Zsolt Nagy, Laszlo Varoczy, Ildiko Pal, Eszter Csanky, Andras Guttman
ELECTROPHORESIS.2017; 38(17): 2115. CrossRef
Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practice
Ho Sup Lee, Chang-Ki Min
The Korean Journal of Internal Medicine.2016; 31(5): 809. CrossRef